A new once daily, non-hormonal pill that reduces hot flushes and night sweats caused by menopause has been approved by the UK’s drugs regulator.12
Fezolinetant, marketed as Veoza, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) for moderate to severe vasomotor symptoms associated with menopause.
BMJ 2023; 383 doi: https://doi.org/10.1136/bmj.p2969 (Published 19 December 2023)
Comments